APA (7th ed.) Citation

Junquan Song, Runyu Yang, Rongyuan Wei, Yue Du, Pengcheng He, & Xiaowen Liu. (2022). Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction. BMC.

Chicago Style (17th ed.) Citation

Junquan Song, Runyu Yang, Rongyuan Wei, Yue Du, Pengcheng He, and Xiaowen Liu. Pan-cancer Analysis Reveals RIPK2 Predicts Prognosis and Promotes Immune Therapy Resistance via Triggering Cytotoxic T Lymphocytes Dysfunction. BMC, 2022.

MLA (9th ed.) Citation

Junquan Song, et al. Pan-cancer Analysis Reveals RIPK2 Predicts Prognosis and Promotes Immune Therapy Resistance via Triggering Cytotoxic T Lymphocytes Dysfunction. BMC, 2022.